The United Laboratories International Holdings Limited provided earnings guidance for the year ended December 31, 2011. For the year, the company expects profit after taxation to decrease materially as compared with last year. The decrease is mainly due the restricted use of antibiotics medicines and the price reduction policies on the finished products launched by the government, continued drop in the prices of bulk medicine and intermediate products, and increase in finance costs as a result of rise of bank borrowing rates in second half of 2011.